216 related articles for article (PubMed ID: 26838385)
1. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women.
Zhang Y; Liu Y; Li L; Wei J; Xiong S; Zhao Z
Talanta; 2016 Apr; 150():88-96. PubMed ID: 26838385
[TBL] [Abstract][Full Text] [Related]
2. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract][Full Text] [Related]
3. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
[TBL] [Abstract][Full Text] [Related]
4. Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass.
Buas MF; Drescher CW; Urban N; Li CI; Bettcher L; Hait NC; Moysich KB; Odunsi K; Raftery D; Yan L
Sci Rep; 2021 Sep; 11(1):18156. PubMed ID: 34518593
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.
Buas MF; Gu H; Djukovic D; Zhu J; Drescher CW; Urban N; Raftery D; Li CI
Gynecol Oncol; 2016 Jan; 140(1):138-44. PubMed ID: 26521694
[TBL] [Abstract][Full Text] [Related]
6. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
[TBL] [Abstract][Full Text] [Related]
7. Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry.
Li J; Xie H; Li A; Cheng J; Yang K; Wang J; Wang W; Zhang F; Li Z; Dhillon HS; Openkova MS; Zhou X; Li K; Hou Y
Oncotarget; 2017 Jul; 8(29):46834-46845. PubMed ID: 27564116
[TBL] [Abstract][Full Text] [Related]
8. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.
Patterson AD; Maurhofer O; Beyoglu D; Lanz C; Krausz KW; Pabst T; Gonzalez FJ; Dufour JF; Idle JR
Cancer Res; 2011 Nov; 71(21):6590-600. PubMed ID: 21900402
[TBL] [Abstract][Full Text] [Related]
9. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
[TBL] [Abstract][Full Text] [Related]
10. UPLC-MS-based serum metabonomics for identifying acute liver injury biomarkers in Chinese miniature pigs.
Ma J; Yu J; Su X; Zhu C; Yang X; Sun H; Chen D; Wang Y; Cao H; Lu J
Toxicol Lett; 2014 Mar; 225(3):358-66. PubMed ID: 24451218
[TBL] [Abstract][Full Text] [Related]
11. Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation.
Gouveia-Figueira S; Späth J; Zivkovic AM; Nording ML
PLoS One; 2015; 10(7):e0132042. PubMed ID: 26186333
[TBL] [Abstract][Full Text] [Related]
12. Lipidomic analysis of plasma, erythrocytes and lipoprotein fractions of cardiovascular disease patients using UHPLC/MS, MALDI-MS and multivariate data analysis.
Holčapek M; Červená B; Cífková E; Lísa M; Chagovets V; Vostálová J; Bancířová M; Galuszka J; Hill M
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():52-63. PubMed ID: 25855318
[TBL] [Abstract][Full Text] [Related]
13. Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer.
Chen J; Zhou L; Zhang X; Lu X; Cao R; Xu C; Xu G
Electrophoresis; 2012 Nov; 33(22):3361-9. PubMed ID: 23109122
[TBL] [Abstract][Full Text] [Related]
14. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
[TBL] [Abstract][Full Text] [Related]
15. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
16. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
17. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
Ji H; Liu Y; He F; An R; Du Z
J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry.
Yang B; Zhang A; Sun H; Dong W; Yan G; Li T; Wang X
J Pharm Biomed Anal; 2012 Jan; 58():113-24. PubMed ID: 22019702
[TBL] [Abstract][Full Text] [Related]
19. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Toyo'oka T; Min JZ; Inagaki S; Higashi T; Kagawa Y
J Proteome Res; 2010 Aug; 9(8):3912-22. PubMed ID: 20557141
[TBL] [Abstract][Full Text] [Related]
20. Correlation of lipidomic composition of cell lines and tissues of breast cancer patients using hydrophilic interaction liquid chromatography/electrospray ionization mass spectrometry and multivariate data analysis.
Cífková E; Lísa M; Hrstka R; Vrána D; Gatěk J; Melichar B; Holčapek M
Rapid Commun Mass Spectrom; 2017 Feb; 31(3):253-263. PubMed ID: 27862481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
